The frontal cortex as a network hub controlling mood and cognition: Probing its neurochemical substrates for improved therapy of psychiatric and neurological disorders
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The frontal cortex as a network hub controlling mood and cognition: Probing its neurochemical substrates for improved therapy of psychiatric and neurological disorders
Authors
Keywords
-
Journal
JOURNAL OF PSYCHOPHARMACOLOGY
Volume 30, Issue 11, Pages 1099-1128
Publisher
SAGE Publications
Online
2016-10-19
DOI
10.1177/0269881116672342
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Silica stationary phase-based on-line sample enrichment coupled with LC-MS/MS for the quantification of dopamine, serotonin and their metabolites in rat brain microdialysates
- (2016) Minjeong Kim et al. ANALYTICA CHIMICA ACTA
- Seed-competent high-molecular-weight tau species accumulates in the cerebrospinal fluid of Alzheimer's disease mouse model and human patients
- (2016) Shuko Takeda et al. ANNALS OF NEUROLOGY
- Positive allosteric modulation of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid glutamate receptors differentially modulates the behavioural effects of citalopram in mouse models of antidepressant and anxiolytic action
- (2016) Ciarán M. Fitzpatrick et al. BEHAVIOURAL PHARMACOLOGY
- Expression of Serotonin2CReceptors in Pyramidal and GABAergic Neurons of Rat Prefrontal Cortex: A Comparison with Striatum
- (2016) Noemí Santana et al. CEREBRAL CORTEX
- Characterisation of Agomelatine-Induced Increase in Liver Enzymes: Frequency and Risk Factors Determined from a Pooled Analysis of 7605 Treated Patients
- (2016) Gabriel Perlemuter et al. CNS DRUGS
- Mice lacking the serotonin 5-HT 2B receptor as an animal model of resistance to selective serotonin reuptake inhibitors antidepressants
- (2016) Silvina Laura Diaz et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- A meta-analysis of randomized, placebo-controlled trials of vortioxetine for the treatment of major depressive disorder in adults
- (2016) Michael E. Thase et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- The Preclinical and Clinical Effects of Vilazodone for the Treatment of Major Depressive Disorder
- (2016) Zeyad T. Sahli et al. Expert Opinion on Drug Discovery
- The Effects of Vortioxetine on Cognitive Function in Patients with Major Depressive Disorder: A Meta-Analysis of Three Randomized Controlled Trials
- (2016) RS McIntyre et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- A meta-analysis of the efficacy of vortioxetine in patients with major depressive disorder (MDD) and high levels of anxiety symptoms
- (2016) David S. Baldwin et al. JOURNAL OF AFFECTIVE DISORDERS
- Validated methods for determination of neurotransmitters and metabolites in rodent brain tissue and extracellular fluid by reversed phase UHPLC–MS/MS
- (2016) Marianne Skov-Skov Bergh et al. JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES
- γ-aminobutyric acid as a metabolite: Interpreting magnetic resonance spectroscopy experiments
- (2016) James FM Myers et al. JOURNAL OF PSYCHOPHARMACOLOGY
- CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis
- (2016) Bob Olsson et al. LANCET NEUROLOGY
- NMDAR inhibition-independent antidepressant actions of ketamine metabolites
- (2016) Panos Zanos et al. NATURE
- Failed trials for central nervous system disorders do not necessarily invalidate preclinical models and drug targets
- (2016) Anton Bespalov et al. NATURE REVIEWS DRUG DISCOVERY
- Altering the course of schizophrenia: progress and perspectives
- (2016) Mark J. Millan et al. NATURE REVIEWS DRUG DISCOVERY
- Involvement of 5-HT 3 receptors in the action of vortioxetine in rat brain: Focus on glutamatergic and GABAergic neurotransmission
- (2016) Maurizio S. Riga et al. NEUROPHARMACOLOGY
- New therapeutic opportunities for 5-HT2C receptor ligands in neuropsychiatric disorders
- (2016) Giuseppe Di Giovanni et al. PHARMACOLOGY & THERAPEUTICS
- Potential involvement of serotonergic signaling in ketamine's antidepressant actions: A critical review
- (2016) Kristian Gaarn du Jardin et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Effects of the glycine reuptake inhibitors bitopertin and RG7118 on glycine in cerebrospinal fluid: results of two proofs of mechanism studies in healthy volunteers
- (2016) Carsten Hofmann et al. PSYCHOPHARMACOLOGY
- Trace Amines and the Trace Amine-Associated Receptor 1: Pharmacology, Neurochemistry, and Clinical Implications
- (2016) Yue Pei et al. Frontiers in Neuroscience
- Ketamine and Rapid-Acting Antidepressants: A Window into a New Neurobiology for Mood Disorder Therapeutics
- (2015) Chadi G. Abdallah et al. Annual Review of Medicine
- Explorative and targeted neuroproteomics in Alzheimer's disease
- (2015) Ann Brinkmalm et al. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
- N-Methyl-D-Aspartate Receptor Antagonist Effects on Prefrontal Cortical Connectivity Better Model Early Than Chronic Schizophrenia
- (2015) Alan Anticevic et al. BIOLOGICAL PSYCHIATRY
- 5-HT6 Receptor Antagonists: Potential Efficacy for the Treatment of Cognitive Impairment in Schizophrenia
- (2015) Natasja de Bruin et al. CURRENT PHARMACEUTICAL DESIGN
- In-vivo pharmacology of Trace-Amine Associated Receptor 1
- (2015) Vincent M. Lam et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Back to the future of psychopharmacology: A perspective on animal models in drug discovery
- (2015) Hendrikus Hendriksen et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- P.1.g.019 Antidepressant- and anxiolytic-like properties of S 47445, a novel positive allosteric modulator of AMPA type glutamate receptors
- (2015) S. Bretin et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Pharmacological targeting of dopamine D3 receptors: Possible clinical applications of selective drugs
- (2015) Emilio Merlo Pich et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Learning from the past and looking to the future: Emerging perspectives for improving the treatment of psychiatric disorders
- (2015) Mark J. Millan et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Agomelatine beyond Borders: Current Evidences of Its Efficacy in Disorders Other than Major Depression
- (2015) Domenico De Berardis et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Adding Sarcosine to Antipsychotic Treatment in Patients with Stable Schizophrenia Changes the Concentrations of Neuronal and Glial Metabolites in the Left Dorsolateral Prefrontal Cortex
- (2015) Dominik Strzelecki et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The Cognitive Effects of Antidepressants in Major Depressive Disorder: A Systematic Review and Meta-Analysis of Randomized Clinical Trials
- (2015) Joshua D Rosenblat et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Convergence of Melatonin and Serotonin (5-HT) Signaling at MT2/5-HT2CReceptor Heteromers
- (2015) Maud Kamal et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Interaction Between Brain Histamine and Serotonin, Norepinephrine, and Dopamine Systems: In Vivo Microdialysis and Electrophysiology Study
- (2015) Gunnar Flik et al. JOURNAL OF MOLECULAR NEUROSCIENCE
- Modulation by Trace Amine-Associated Receptor 1 of Experimental Parkinsonism, L-DOPA Responsivity, and Glutamatergic Neurotransmission
- (2015) A. Alvarsson et al. JOURNAL OF NEUROSCIENCE
- Involvement of serotonergic system in the effect of a metabotropic glutamate 5 receptor antagonist in the novelty-suppressed feeding test
- (2015) Kenichi Fukumoto et al. JOURNAL OF PHARMACOLOGICAL SCIENCES
- Detection and quantification of microRNA in cerebral microdialysate
- (2015) Søren Bache et al. Journal of Translational Medicine
- Neuroinflammation in Alzheimer's disease
- (2015) Michael T Heneka et al. LANCET NEUROLOGY
- Clinical assessment of social cognitive function in neurological disorders
- (2015) Julie D. Henry et al. Nature Reviews Neurology
- Tau and neurodegenerative disease: the story so far
- (2015) Khalid Iqbal et al. Nature Reviews Neurology
- Prolonged treatment with pramipexole promotes physical interaction of striatal dopamine D3 autoreceptors with dopamine transporters to reduce dopamine uptake
- (2015) Javier Castro-Hernández et al. NEUROBIOLOGY OF DISEASE
- Homeoprotein Signaling in the Developing and Adult Nervous System
- (2015) Alain Prochiantz et al. NEURON
- Long-term administration of the antidepressant vilazodone modulates rat brain monoaminergic systems
- (2015) Mostafa El Mansari et al. NEUROPHARMACOLOGY
- Vortioxetine, a novel antidepressant with multimodal activity: Review of preclinical and clinical data
- (2015) Connie Sanchez et al. PHARMACOLOGY & THERAPEUTICS
- 5-HT7 receptor modulates GABAergic transmission in the rat dorsal raphe nucleus and controls cortical release of serotonin
- (2015) Magdalena Kusek et al. Frontiers in Cellular Neuroscience
- AMPA Receptor–mTOR Activation is Required for the Antidepressant-Like Effects of Sarcosine during the Forced Swim Test in Rats: Insertion of AMPA Receptor may Play a Role
- (2015) Kuang-Ti Chen et al. Frontiers in Behavioral Neuroscience
- A role for D-aspartate oxidase in schizophrenia and in schizophrenia-related symptoms induced by phencyclidine in mice
- (2015) F Errico et al. Translational Psychiatry
- d-serine levels in Alzheimer’s disease: implications for novel biomarker development
- (2015) C Madeira et al. Translational Psychiatry
- Chronic corticosterone-mediated dysregulation of microRNA network in prefrontal cortex of rats: relevance to depression pathophysiology
- (2015) Y Dwivedi et al. Translational Psychiatry
- Therapeutic potential of mGluR5 targeting in Alzheimer's disease
- (2015) Anil Kumar et al. Frontiers in Neuroscience
- Creating Patient-Specific Neural Cells for the In Vitro Study of Brain Disorders
- (2015) Kristen J. Brennand et al. Stem Cell Reports
- Functional and Structural Remodeling of Glutamate Synapses in Prefrontal and Frontal Cortex Induced by Behavioral Stress
- (2015) Laura Musazzi et al. Frontiers in Psychiatry
- The potential of microRNAs as biofluid markers of neurodegenerative diseases – a systematic review
- (2014) Pia B. Danborg et al. BIOMARKERS
- Serotonin 5-HT4 receptors and forebrain cholinergic system: receptor expression in identified cell populations
- (2014) Raúl Peñas-Cazorla et al. Brain Structure & Function
- Serotonin 5-HT4 Receptors: A New Strategy for Developing Fast Acting Antidepressants?
- (2014) Rebeca Vidal et al. CURRENT PHARMACEUTICAL DESIGN
- S.12.02 Absence of D-serine results in abnormal dopamine–glutamate dialogue in the prefrontal cortex
- (2014) G. Dallerac et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- A phase II/III trial of bitopertin monotherapy compared with placebo in patients with an acute exacerbation of schizophrenia – Results from the CandleLyte study
- (2014) D. Bugarski-Kirola et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Efficacy of vilazodone on anxiety symptoms in patients with major depressive disorder
- (2014) Michael E. Thase et al. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
- Antidepressant drug development: Focus on triple monoamine reuptake inhibition
- (2014) Roger M Lane JOURNAL OF PSYCHOPHARMACOLOGY
- Loss of Phenotype of Parvalbumin Interneurons in Rat Prefrontal Cortex Is Involved in Antidepressant- and Propsychotic-Like Behaviors Following Acute and Repeated Ketamine Administration
- (2014) ZhiQiang Zhou et al. MOLECULAR NEUROBIOLOGY
- Brain Oxytocin in Social Fear Conditioning and Its Extinction: Involvement of the Lateral Septum
- (2014) Iulia Zoicas et al. NEUROPSYCHOPHARMACOLOGY
- Serotonin 1A and Serotonin 4 Receptors
- (2014) Benjamin Adam Samuels et al. NEUROSCIENTIST
- NMDA but not AMPA glutamatergic receptors are involved in the antidepressant-like activity of MTEP during the forced swim test in mice
- (2014) Lucyna Pomierny-Chamioło et al. Pharmacological Reports
- Is the mGlu5 receptor a possible target for new antidepressant drugs?
- (2014) Agnieszka Pałucha-Poniewiera et al. Pharmacological Reports
- Organization, control and function of extrasynaptic NMDA receptors
- (2014) T. Papouin et al. PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
- Glutamatergic abnormalities in schizophrenia: A review of proton MRS findings
- (2014) Eline M.P. Poels et al. SCHIZOPHRENIA RESEARCH
- Effect of Bitopertin, a Glycine Reuptake Inhibitor, on Negative Symptoms of Schizophrenia
- (2014) Daniel Umbricht et al. JAMA Psychiatry
- Serotonergic modulation of glutamate neurotransmission as a strategy for treating depression and cognitive dysfunction
- (2013) Alan L. Pehrson et al. CNS SPECTRUMS
- Electrophysiological evidence for rapid 5-HT1A autoreceptor inhibition by vilazodone, a 5-HT1A receptor partial agonist and 5-HT reuptake inhibitor
- (2013) Charles R. Ashby et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- The potential role of dopamine D3 receptor neurotransmission in cognition
- (2013) Shinichiro Nakajima et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Molecular mechanism of histamine clearance by primary human astrocytes
- (2013) Takeo Yoshikawa et al. GLIA
- Efficacy of the novel antidepressant agomelatine for anxiety symptoms in major depression
- (2013) Dan J Stein et al. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
- On ‘polypharmacy’ and multi-target agents, complementary strategies for improving the treatment of depression: a comparative appraisal
- (2013) Mark J. Millan INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Monitoring of β-Amyloid Dynamics after Human Traumatic Brain Injury
- (2013) Niklas Marklund et al. JOURNAL OF NEUROTRAUMA
- Dopamine D3 receptor antagonism—still a therapeutic option for the treatment of schizophrenia
- (2013) Gerhard Gross et al. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
- Therapeutic doses of antidepressants are projected not to inhibit human α4β2 nicotinic acetylcholine receptors
- (2013) Mark L. Weber et al. NEUROPHARMACOLOGY
- Towards improved animal models for evaluating social cognition and its disruption in schizophrenia: The CNTRICS initiative
- (2013) Mark J. Millan et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Serotonin and beyond: therapeutics for major depression
- (2013) P. Blier et al. PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
- Trace Amine-Associated Receptor 1 Partial Agonism Reveals Novel Paradigm for Neuropsychiatric Therapeutics
- (2012) Florent G. Revel et al. BIOLOGICAL PSYCHIATRY
- Quantification of extracellular levels of corticosterone in the basolateral amygdaloid complex of freely-moving rats: A dialysis study of circadian variation and stress-induced modulation
- (2012) Gaëlle Bouchez et al. BRAIN RESEARCH
- Emerging Targets for the Pharmacological Treatment of Depression: Focus on Melatonergic System
- (2012) Mario Catena-Dell'Osso et al. CURRENT MEDICINAL CHEMISTRY
- 5-HT6receptor recruitment of mTOR as a mechanism for perturbed cognition in schizophrenia
- (2012) Julie Meffre et al. EMBO Molecular Medicine
- Cortical circuit dysfunction and cognitive deficits in schizophrenia - implications for preemptive interventions
- (2012) David A. Lewis EUROPEAN JOURNAL OF NEUROSCIENCE
- Lu AA21004, a novel multimodal antidepressant, produces regionally selective increases of multiple neurotransmitters—A rat microdialysis and electrophysiology study
- (2012) Alan L. Pehrson et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- A randomized, double-blind, placebo-controlled, duloxetine-referenced, fixed-dose study comparing the efficacy and safety of Lu AA21004 in elderly patients with major depressive disorder
- (2012) Cornelius Katona et al. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
- Simultaneous oxytocin and arg-vasopressin measurements in microdialysates using capillary liquid chromatography–mass spectrometry
- (2012) Omar S. Mabrouk et al. JOURNAL OF NEUROSCIENCE METHODS
- Examination of Org 26576, an AMPA receptor positive allosteric modulator, in patients diagnosed with major depressive disorder: an exploratory, randomized, double-blind, placebo-controlled trial
- (2012) Kari R Nations et al. JOURNAL OF PSYCHOPHARMACOLOGY
- V1b and CRHR1 Receptor Heterodimerization Mediates Synergistic Biological Actions of Vasopressin and CRH
- (2012) Brigitte Murat et al. MOLECULAR ENDOCRINOLOGY
- Advancing schizophrenia drug discovery: optimizing rodent models to bridge the translational gap
- (2012) Judith Pratt et al. NATURE REVIEWS DRUG DISCOVERY
- Cognitive dysfunction in psychiatric disorders: characteristics, causes and the quest for improved therapy
- (2012) Mark J. Millan et al. NATURE REVIEWS DRUG DISCOVERY
- Concurrent modulation of extracellular levels of noradrenaline and cAMP during stress and by anxiogenic- or anxiolytic-like neuropeptides in the prefrontal cortex of awake rats
- (2012) Shimako Yoshitake et al. NEUROCHEMISTRY INTERNATIONAL
- The mGlu5 receptor antagonist MPEP activates specific stress-related brain regions and lacks neurotoxic effects of the NMDA receptor antagonist MK-801: Significance for the use as anxiolytic/antidepressant drug
- (2012) Dragos Inta et al. NEUROPHARMACOLOGY
- An epigenetic framework for neurodevelopmental disorders: From pathogenesis to potential therapy
- (2012) Mark J. Millan NEUROPHARMACOLOGY
- Negative allosteric modulation of metabotropic glutamate receptor 5 results in broad spectrum activity relevant to treatment resistant depression
- (2012) Z.A. Hughes et al. NEUROPHARMACOLOGY
- Applied strategies towards EEG/MEG biomarker identification in clinical and cognitive research
- (2011) Vangelis Sakkalis Biomarkers in Medicine
- Glial D-Serine Gates NMDA Receptors at Excitatory Synapses in Prefrontal Cortex
- (2011) Pascal Fossat et al. CEREBRAL CORTEX
- MicroRNA in the regulation and expression of serotonergic transmission in the brain and other tissues
- (2011) Mark J Millan CURRENT OPINION IN PHARMACOLOGY
- The role of cortical and hypothalamic histamine-3 receptors in the modulation of central histamine neurotransmission: an in vivo electrophysiology and microdialysis study
- (2011) Gunnar Flik et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- Advances in multidisciplinary and cross-species approaches to examine the neurobiology of psychiatric disorders
- (2011) Martien J.H. Kas et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Molecular adaptation to chronic antidepressant treatment: evidence for a more rapid response to the novel α2-adrenoceptor antagonist/5-HT-noradrenaline reuptake inhibitor (SNRI), S35966, compared to the SNRI, venlafaxine
- (2011) Florence Serres et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Regulation of dorsal raphe nucleus function by serotonin autoreceptors: A behavioral perspective
- (2011) Ross A. McDevitt et al. JOURNAL OF CHEMICAL NEUROANATOMY
- Discovery of 1-[2-(2,4-Dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): A Novel Multimodal Compound for the Treatment of Major Depressive Disorder
- (2011) Benny Bang-Andersen et al. JOURNAL OF MEDICINAL CHEMISTRY
- Pre-synaptic dopamine D3 receptor mediates cocaine-induced structural plasticity in mesencephalic dopaminergic neurons via ERK and Akt pathways
- (2011) Ginetta Collo et al. JOURNAL OF NEUROCHEMISTRY
- Characterization of an mGluR2/3 Negative Allosteric Modulator in Rodent Models of Depression
- (2011) Brice Campo et al. JOURNAL OF NEUROGENETICS
- Genetic Deletion of Trace Amine 1 Receptors Reveals Their Role in Auto-Inhibiting the Actions of Ecstasy (MDMA)
- (2011) B. Di Cara et al. JOURNAL OF NEUROSCIENCE
- Simultaneous quantification of d- vs. l-serine, taurine, kynurenate, phosphoethanolamine and diverse amino acids in frontocortical dialysates of freely-moving rats: Differential modulation by N-methyl-d-aspartate (NMDA) and other pharmacological agents
- (2011) Alain Gobert et al. JOURNAL OF NEUROSCIENCE METHODS
- Upregulation of Endogenous Neurotrophin Levels in the Brain by Intranasal Administration of Carnosic Acid
- (2011) Siva Ram Kiran Vaka et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Causal role of the prefrontal cortex in top-down modulation of visual processing and working memory
- (2011) Theodore P Zanto et al. NATURE NEUROSCIENCE
- Glycine reuptake inhibitor RG1678: A pharmacologic characterization of an investigational agent for the treatment of schizophrenia
- (2011) Daniela Alberati et al. NEUROPHARMACOLOGY
- Selective Blockade of Dopamine D3 Receptors Enhances while D2 Receptor Antagonism Impairs Social Novelty Discrimination and Novel Object Recognition in Rats: A Key Role for the Prefrontal Cortex
- (2011) David JG Watson et al. NEUROPSYCHOPHARMACOLOGY
- Pharmacological Blockade of 5-HT7 Receptors as a Putative Fast Acting Antidepressant Strategy
- (2011) Ouissame Mnie-Filali et al. NEUROPSYCHOPHARMACOLOGY
- The Role of Alpha2-Adrenergic Agonists in Attention-Deficit/Hyperactivity Disorder
- (2011) Floyd R. Sallee POSTGRADUATE MEDICINE
- Cholinergic receptor subtypes and their role in cognition, emotion, and vigilance control: An overview of preclinical and clinical findings
- (2011) Susanne Graef et al. PSYCHOPHARMACOLOGY
- Interaction between Diazepam and Hippocampal Corticosterone after Acute Stress: Impact on Memory in Middle-Aged Mice
- (2011) Daniel Béracochéa et al. Frontiers in Behavioral Neuroscience
- Increased Synaptic Dopamine Function in Associative Regions of the Striatum in Schizophrenia
- (2010) Lawrence S. Kegeles et al. ARCHIVES OF GENERAL PSYCHIATRY
- N-methyl-d-aspartate (NMDA) receptor dysfunction or dysregulation: The final common pathway on the road to schizophrenia?
- (2010) Joshua T. Kantrowitz et al. BRAIN RESEARCH BULLETIN
- Neurotransmitter transporters expressed in glial cells as regulators of synapse function
- (2010) Volker Eulenburg et al. BRAIN RESEARCH REVIEWS
- Trace amines depress D2-autoreceptor-mediated responses on midbrain dopaminergic cells
- (2010) Ada Ledonne et al. BRITISH JOURNAL OF PHARMACOLOGY
- Nonapeptide mechanisms of social cognition, behavior and species-specific social systems
- (2010) James L Goodson et al. CURRENT OPINION IN NEUROBIOLOGY
- Strategies to Enhance N-Methyl-D-Aspartate Receptor-Mediated Neurotransmission in Schizophrenia, a Critical Review and Meta-Analysis
- (2010) Guochuan Tsai et al. CURRENT PHARMACEUTICAL DESIGN
- Histamine H3 Antagonists for Treatment of Cognitive Deficits in CNS Diseases
- (2010) Rita Raddatz et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Multiple origins of the cortical gamma rhythm
- (2010) Miles A. Whittington et al. Developmental Neurobiology
- S41744, a dual neurokinin (NK)1 receptor antagonist and serotonin (5-HT) reuptake inhibitor with potential antidepressant properties: A comparison to aprepitant (MK869) and paroxetine
- (2010) Mark J. Millan et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- The use of PET imaging in studying cognition, genetics and pharmacotherapeutic interventions in schizophrenia
- (2010) Nora S Vyas et al. Expert Review of Neurotherapeutics
- Antidepressant-like effects of an AMPA receptor potentiator under a chronic mild stress paradigm
- (2010) Severine Farley et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- The melatonergic agonist and clinically active antidepressant, agomelatine, is a neutral antagonist at 5-HT2C receptors
- (2010) Mark J. Millan et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- The emerging role of trace amine-associated receptor 1 in the functional regulation of monoamine transporters and dopaminergic activity
- (2010) Gregory M. Miller JOURNAL OF NEUROCHEMISTRY
- High-Frequency Stimulation of the Subthalamic Nucleus and L-3,4-Dihydroxyphenylalanine Inhibit In Vivo Serotonin Release in the Prefrontal Cortex and Hippocampus in a Rat Model of Parkinson's Disease
- (2010) S. Navailles et al. JOURNAL OF NEUROSCIENCE
- The effects of the glycine reuptake inhibitor R213129 on the central nervous system and on scopolamine-induced impairments in psychomotor and cognitive function in healthy subjects
- (2010) M Liem-Moolenaar et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Using MRI to measure drug action: caveats and new directions
- (2010) Susannah E Murphy et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Erratum: Agomelatine, the first melatonergic antidepressant: discovery, characterization and development
- (2010) Christian de Bodinat et al. NATURE REVIEWS DRUG DISCOVERY
- Alterations in Brain Extracellular Dopamine and Glycine Levels Following Combined Administration of the Glycine Transporter Type-1 Inhibitor Org-24461 and Risperidone
- (2010) Katalin Nagy et al. NEUROCHEMICAL RESEARCH
- Mechanism-based approaches to treating fragile X
- (2010) Gül Dölen et al. PHARMACOLOGY & THERAPEUTICS
- Activation of AMPA Receptors in the Suprachiasmatic Nucleus Phase-Shifts the Mouse Circadian Clock In Vivo and In Vitro
- (2010) Yasutaka Mizoro et al. PLoS One
- d-Serine and a glycine transporter-1 inhibitor enhance social memory in rats
- (2010) Toshiharu Shimazaki et al. PSYCHOPHARMACOLOGY
- E-6801, a 5-HT6 receptor agonist, improves recognition memory by combined modulation of cholinergic and glutamatergic neurotransmission in the rat
- (2010) Ian Kendall et al. PSYCHOPHARMACOLOGY
- The FDA-NIMH-MATRICS Guidelines for Clinical Trial Design of Cognitive-Enhancing Drugs: What Do We Know 5 Years Later?
- (2010) R. W. Buchanan et al. SCHIZOPHRENIA BULLETIN
- Interactions of the circadian CLOCK system and the HPA axis
- (2010) Nancy Nader et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- The Neuropsychopharmacology of Fronto-Executive Function: Monoaminergic Modulation
- (2009) T.W. Robbins et al. Annual Review of Neuroscience
- MicroRNAs: Target Recognition and Regulatory Functions
- (2009) David P. Bartel CELL
- Pharmacological Manipulation of Kynurenic Acid
- (2009) Sophie Erhardt et al. CNS DRUGS
- Distinct, Time-Dependent Effects of Voluntary Exercise on Circadian and Ultradian Rhythms and Stress Responses of Free Corticosterone in the Rat Hippocampus
- (2009) Susanne K. Droste et al. ENDOCRINOLOGY
- Cognitive impairment in major depression
- (2009) Donatella Marazziti et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Glucocorticoids and the regulation of memory in health and disease
- (2009) Dominique J.-F. de Quervain et al. FRONTIERS IN NEUROENDOCRINOLOGY
- The effects of energy drinks alone and with alcohol on neuropsychological functioning
- (2009) Kim Curry et al. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
- Monitoring of brain interstitial total tau and beta amyloid proteins by microdialysis in patients with traumatic brain injury
- (2009) Niklas Marklund et al. JOURNAL OF NEUROSURGERY
- Effects of stress throughout the lifespan on the brain, behaviour and cognition
- (2009) Sonia J. Lupien et al. NATURE REVIEWS NEUROSCIENCE
- Potentiation of Gamma Oscillatory Activity through Repetitive Transcranial Magnetic Stimulation of the Dorsolateral Prefrontal Cortex
- (2009) Mera S Barr et al. NEUROPSYCHOPHARMACOLOGY
- Mechanisms Contributing to the Phase-Dependent Regulation of Neurogenesis by the Novel Antidepressant, Agomelatine, in the Adult Rat Hippocampus
- (2009) Amélie Soumier et al. NEUROPSYCHOPHARMACOLOGY
- Characterization of the oxytocin system regulating affiliative behavior in female prairie voles
- (2009) H.E. Ross et al. NEUROSCIENCE
- Using the MATRICS to guide development of a preclinical cognitive test battery for research in schizophrenia
- (2009) Jared W. Young et al. PHARMACOLOGY & THERAPEUTICS
- Self-administered and passive cocaine infusions produce different effects on corticosterone concentrations in the medial prefrontal cortex (MPC) of rats
- (2009) Vitaly Palamarchouk et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- The Social Brain: Neural Basis of Social Knowledge
- (2008) Ralph Adolphs Annual Review of Psychology
- Blockade of dopamine D3 receptors in frontal cortex, but not in sub-cortical structures, enhances social recognition in rats: Similar actions of D1 receptor agonists, but not of D2 antagonists
- (2008) Florence Loiseau et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Thematic Review Series: Glycerolipids.Phosphatidylserine and phosphatidylethanolamine in mammalian cells: two metabolically related aminophospholipids
- (2008) Jean E. Vance JOURNAL OF LIPID RESEARCH
- Metabotropic Glutamate Receptor Type 5-Dependent Long-Term Potentiation of Excitatory Synapses on Fast-Spiking GABAergic Neurons in Mouse Visual Cortex
- (2008) A. Sarihi et al. JOURNAL OF NEUROSCIENCE
- Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders
- (2008) Gerard Sanacora et al. NATURE REVIEWS DRUG DISCOVERY
- Neurokinin1 Antagonists Potentiate Antidepressant Properties of Serotonin Reuptake Inhibitors, Yet Blunt Their Anxiogenic Actions: A Neurochemical, Electrophysiological and Behavioral Characterization
- (2008) Alain Gobert et al. NEUROPSYCHOPHARMACOLOGY
- Stress-induced prefrontal reorganization and executive dysfunction in rodents
- (2008) Andrew Holmes et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Dual- and triple-acting agents for treating core and co-morbid symptoms of major depression: novel concepts, new drugs
- (2008) Mark J. Millan Neurotherapeutics
- Allosteric modulation of NMDA receptor via elevation of brain glycine and d-serine: The therapeutic potentials for schizophrenia
- (2008) Charles R. Yang et al. PHARMACOLOGY & THERAPEUTICS
- Listening to neuropeptides by microdialysis: Echoes and new sounds?
- (2008) Carsten T. Wotjak et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- S32006, a novel 5-HT2C receptor antagonist displaying broad-based antidepressant and anxiolytic properties in rodent models
- (2008) Anne Dekeyne et al. PSYCHOPHARMACOLOGY
- Cognitive Impairment in Schizophrenia: a Review of Developmental and Genetic Models, and Pro-cognitive Profile of the Optimised D3 > D2 Antagonist, S33138
- (2008) Mark J. Millan et al. THERAPIE
- A role for the 5-HT1A, 5-HT4 and 5-HT6 receptors in learning and memory
- (2008) M KING et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Microdialysis of GABA and glutamate: Analysis, interpretation and comparison with microsensors
- (2007) Miranda van der Zeyden et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now